Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis
Public ClinicalTrials.gov record NCT00195676. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter Open-Label Continuation Study in Moderate to Severe Chronic Plaque Psoriasis Subjects Who Completed a Preceding Psoriasis Clinical Study With Adalimumab
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The two objectives of this study were to evaluate long-term efficacy and safety of adalimumab treatment in participants who had moderate to severe chronic plaque psoriasis and to evaluate the effectiveness of adalimumab retreatment in participants who had therapeutic response to adalimumab and were then withdrawn from adalimumab treatment.
Study identification
- NCT ID
- NCT00195676
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,469 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2004
- Primary completion
- Sep 30, 2009
- Completion
- Sep 30, 2009
- Last update posted
- Apr 12, 2011
2004 – 2009
United States locations
- U.S. sites
- 66
- U.S. states
- 30
- U.S. cities
- 60
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site Reference ID/Investigator# 1263 | Birmingham | Alabama | 35205 | — |
| Site Reference ID/Investigator# 1259 | Buckner 13075 PI | Alabama | 35233 | — |
| Site Reference ID/Investigator# 2427 | Scottsdale | Arizona | 85251 | — |
| Site Reference ID/Investigator# 2433 | Tucson | Arizona | 85710 | — |
| Site Reference ID/Investigator# 100 | Little Rock | Arkansas | 72205 | — |
| Site Reference ID/Investigator# 1798 | Bakersfield | California | 93309 | — |
| Site Reference ID/Investigator# 122 | Fresno | California | 93720 | — |
| Site Reference ID/Investigator# 1669 | Irvine | California | 92697 | — |
| Site Reference ID/Investigator# 1285 | Oceanside | California | 92056 | — |
| Site Reference ID/Investigator# 86 | San Diego | California | 92123 | — |
| Site Reference ID/Investigator# 1679 | Santa Monica | California | 90404 | — |
| Site Reference ID/Investigator# 1677 | Torrance | California | 90503 | — |
| Site Reference ID/Investigator# 1269 | Longmont | Colorado | 80501 | — |
| Site Reference ID/Investigator# 1275 | New Haven | Connecticut | 06511 | — |
| Site Reference ID/Investigator# 96 | Jacksonville | Florida | 32204 | — |
| Site Reference ID/Investigator# 2431 | Pinellas Park | Florida | 33781 | — |
| Site Reference ID/Investigator# 1273 | South Miami | Florida | 33143 | — |
| Site Reference ID/Investigator# 2432 | West Palm Beach | Florida | 33407 | — |
| Site Reference ID/Investigator# 98 | Alpharetta | Georgia | 30022 | — |
| Site Reference ID/Investigator# 1674 | Newnan | Georgia | 30263 | — |
| Site Reference ID/Investigator# 1670 | Snellville | Georgia | 30078 | — |
| Site Reference ID/Investigator# 1264 | Chicago | Illinois | 60612 | — |
| Site Reference ID/Investigator# 1801 | Maywood | Illinois | 60153 | — |
| Site Reference ID/Investigator# 1681 | Springfield | Illinois | 62702 | — |
| Site Reference ID/Investigator# 1267 | Indianapolis | Indiana | 46256 | — |
| Site Reference ID/Investigator# 1671 | Indianapolis | Indiana | 46260 | — |
| Site Reference ID/Investigator# 1258 | Louisville | Kentucky | 40202 | — |
| Site Reference ID/Investigator# 1281 | Shreveport | Louisiana | 71103 | — |
| Site Reference ID/Investigator# 1668 | Andover | Massachusetts | 01810 | — |
| Site Reference ID/Investigator# 1683 | Boston | Massachusetts | 02114 | — |
| Site Reference ID/Investigator# 83 | Worcester | Massachusetts | 01610 | — |
| Site Reference ID/Investigator# 93 | Ann Arbor | Michigan | 48109 | — |
| Site Reference ID/Investigator# 92 | Fridley | Minnesota | 55432 | — |
| Site Reference ID/Investigator# 1262 | Minneapolis | Minnesota | 55455 | — |
| Site Reference ID/Investigator# 1657 | St Louis | Missouri | 63110 | — |
| Site Reference ID/Investigator# 89 | St Louis | Missouri | 63117 | — |
| Site Reference ID/Investigator# 1673 | Omaha | Nebraska | 68131 | — |
| Site Reference ID/Investigator# 2119 | New Brunswick | New Jersey | 08903 | — |
| Site Reference ID/Investigator# 1672 | New York | New York | 10016 | — |
| Site Reference ID/Investigator# 1797 | New York | New York | 10025 | — |
| Site Reference ID/Investigator# 95 | New York | New York | 10029 | — |
| Site Reference ID/Investigator# 1655 | New York | New York | 10032 | — |
| Site Reference ID/Investigator# 88 | Rochester | New York | 14623 | — |
| Site Reference ID/Investigator# 1256 | Williamsville | New York | 14221 | — |
| Site Reference ID/Investigator# 1266 | Raleigh | North Carolina | 27612 | — |
| Site Reference ID/Investigator# 1265 | Cincinnati | Ohio | 45219 | — |
| Site Reference ID/Investigator# 90 | Cleveland | Ohio | 44106 | — |
| Site Reference ID/Investigator# 2434 | Columbus | Ohio | 43212 | — |
| Site Reference ID/Investigator# 1260 | Lake Oswego | Oregon | 97035 | — |
| Site Reference ID/Investigator# 1667 | Portland | Oregon | 97210 | — |
| Site Reference ID/Investigator# 121 | Portland | Oregon | 97223 | — |
| Site Reference ID/Investigator# 1323 | Hershey | Pennsylvania | 17033 | — |
| Site Reference ID/Investigator# 1277 | Philadelphia | Pennsylvania | 19103 | — |
| Site Reference ID/Investigator# 99 | Johnston | Rhode Island | 02919 | — |
| Site Reference ID/Investigator# 1676 | Providence | Rhode Island | 02903 | — |
| Site Reference ID/Investigator# 97 | Greer | South Carolina | 29651 | — |
| Site Reference ID/Investigator# 5199 | Mt. Pleasant | South Carolina | 29464 | — |
| Site Reference ID/Investigator# 1800 | Goodlettsville | Tennessee | 37072 | — |
| Site Reference ID/Investigator# 1282 | Nashville | Tennessee | 37215 | — |
| Site Reference ID/Investigator# 87 | Dallas | Texas | 75246-1613 | — |
| Site Reference ID/Investigator# 1279 | Houston | Texas | 77030 | — |
| Site Reference ID/Investigator# 1665 | San Antonio | Texas | 78229 | — |
| Site Reference ID/Investigator# 1268 | Tyler | Texas | 75703 | — |
| Site Reference ID/Investigator# 2079 | Salt Lake City | Utah | 84132 | — |
| Site Reference ID/Investigator# 123 | Norfolk | Virginia | 23507 | — |
| Site Reference ID/Investigator# 1653 | Seattle | Washington | 98101 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 38 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00195676, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 12, 2011 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00195676 live on ClinicalTrials.gov.